🌎 First Solar Upgraded, Sunrun Downgraded, UnitedHealth Group Downgraded and more…
RJ Hamster
Advertisements
Ratings changes for First Solar, Sunrun, Summit Therapeutics, Travere Therapeutics, PDS Biotechnology, Microsoft, Insmed and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Microsoft Co. (NASDAQ:MSFT) announced a quarterly dividend on Tuesday, March 11th. Stockholders of record on Thursday, May 15th will be paid a dividend of 0.83 per share by the software giant on Thursday, June 12th. This represents a $3.32 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date of this dividend is Thursday, May 15th.
Microsoft Co. (NASDAQ:MSFT) announced a quarterly dividend on Tuesday, June 10th. Investors of record on Thursday, August 21st will be paid a dividend of 0.83 per share by the software giant on Thursday, September 11th. This represents a $3.32 dividend on an annualized basis and a dividend yield of 0.71%.
Microsoft (NASDAQ:MSFT) had its price target raised by analysts at Citigroup Inc. () from $540.00 to $605.00. They now have a “buy” rating on the stock. This represents a 28.5% upside from the current price of $470.92.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at Kepler Capital Markets from a “hold” rating to a “buy” rating.The current price is $7.62.
Banco Santander (Brasil) (NYSE:BSBR) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating.The current price is $5.35.
First Solar (NASDAQ:FSLR) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $192.00 price target on the stock, up previously from $157.00. This represents a 12.9% upside from the current price of $169.99.
J. M. Smucker (NYSE:SJM) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $115.00 price target on the stock, down previously from $118.00. This represents a 19.7% upside from the current price of $96.07.
Urban Outfitters (NASDAQ:URBN) was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $90.00 price target on the stock, up previously from $75.00. This represents a 28.3% upside from the current price of $70.13.
Arista Networks (NYSE:ANET) was downgraded by analysts at BNP Paribas Exane from an “outperform” rating to a “neutral” rating. They now have a $106.00 price target on the stock. This represents a 13.7% upside from the current price of $93.23.
BILL (NYSE:BILL) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $55.00 price target on the stock. This represents a 22.6% upside from the current price of $44.88.
Etsy (NASDAQ:ETSY) was downgraded by analysts at Arete from a “neutral” rating to a “sell” rating. They now have a $43.00 price target on the stock. This represents a 28.5% downside from the current price of $60.16.
GitLab (NASDAQ:GTLB) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $50.00 price target on the stock. This represents a 17.1% upside from the current price of $42.69.
Ingram Micro (NYSE:INGM) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $22.00 price target on the stock. This represents a 12.6% upside from the current price of $19.55.
Sunrun (NASDAQ:RUN) was downgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to an “underperform” rating. They now have a $5.00 price target on the stock, down previously from $6.00. This represents a 42.1% downside from the current price of $8.63.
UnitedHealth Group (NYSE:UNH) was downgraded by analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating. They now have a $312.00 price target on the stock. This represents a 1.9% upside from the current price of $306.06.
Core Natural Resources (NYSE:CNR) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $80.00 price target on the stock. This represents a 18.7% upside from the current price of $67.38.
Coinbase Global (NASDAQ:COIN) is now covered by analysts at William Blair. They set an “outperform” rating on the stock.The current price is $256.23.
Gold Royalty (NYSE:GROY) is now covered by analysts at Canaccord Genuity Group Inc.. They set a “buy” rating and a $3.00 price target on the stock. This represents a 46.0% upside from the current price of $2.06.
Pharvaris (NASDAQ:PHVS) is now covered by analysts at Guggenheim. They set a “buy” rating and a $32.00 price target on the stock. This represents a 78.7% upside from the current price of $17.91.
Photronics (NASDAQ:PLAB) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $32.00 price target on the stock. This represents a 67.6% upside from the current price of $19.09.
QXO (NASDAQ:QXO) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $27.00 price target on the stock. This represents a 33.4% upside from the current price of $20.25.
Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Raymond James. They set a “strong-buy” rating and a $65.00 price target on the stock. This represents a 95.4% upside from the current price of $33.27.
Summit Therapeutics (NASDAQ:SMMT) is now covered by analysts at Leerink Partners. They set an “underperform” rating and a $12.00 price target on the stock. This represents a 43.8% downside from the current price of $21.35.
TD SYNNEX (NYSE:SNX) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $145.00 price target on the stock. This represents a 13.1% upside from the current price of $128.22.
Uber Technologies (NYSE:UBER) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $110.00 price target on the stock. This represents a 27.0% upside from the current price of $86.64.
Venu (NYSEAMERICAN:VENU) is now covered by analysts at Northland Securities. They set an “outperform” rating and a $15.00 price target on the stock. This represents a 35.5% upside from the current price of $11.07.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
